Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12345758 | 0.81 | MAPT (0.33) | — | |
| SCHEMBL14603456 | 0.79 | EGFR (0.35) | — | |
| SCHEMBL12712018 | 0.77 | — | — | |
| SCHEMBL24404197 | 0.77 | GAA (0.32) | — | |
| SCHEMBL1102387 | 0.77 | — | — | |
| SCHEMBL15260402 | 0.77 | CYP3A4 (0.32) | GSK3B | |
| SCHEMBL10028812 | 0.75 | GPR3 (0.36) | — | |
| SCHEMBL19267320 | 0.73 | — | — | |
| SCHEMBL12711672 | 0.72 | — | — | |
| SCHEMBL28269421 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10113065-B1 | Two-photon absorbing compounds and methods of making same | GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE | 2018-10-30 | — | — | US | disclosed |
| EP-3178823-A1 | CHARGE TRANSPORTING MATERIAL FOR OPTOELECTRONIC AND/OR PHOTOELECTROCHEMICAL DEVICES | Ecole Polytechnique Fédérale de Lausanne (EPFL) (CH) | 2017-06-14 | — | — | EP | disclosed |
| EP-2361915-B1 | NOVEL HETEROCYCLIC COMPOUND AND USE THEREOF | NIPPON KAYAKU KK (JP) | 2015-01-28 | — | — | EP | disclosed |
| EP-2361915-B1 | NOVEL HETEROCYCLIC COMPOUND AND USE THEREOF | NIPPON KAYAKU KK (JP) | 2015-01-28 | — | — | EP | disclosed |
| US-8313671-B2 | Heterocyclic compound and use thereof | HIROSHIMA UNIVERSITY (JP) | 2012-11-20 | — | — | US | disclosed |
| US-8313671-B2 | Heterocyclic compound and use thereof | HIROSHIMA UNIVERSITY (JP) | 2012-11-20 | — | — | US | disclosed |
| US-8313671-B2 | Heterocyclic compound and use thereof | HIROSHIMA UNIVERSITY (JP) | 2012-11-20 | — | — | US | disclosed |
| EP-2361915-A1 | NOVEL HETEROCYCLIC COMPOUND AND USE THEREOF | Hiroshima University (JP) | 2011-08-31 | — | — | EP | disclosed |
| US-20110204295-A1 | Novel Heterocyclic Compound And Use Thereof | HIROSHIMA UNIVERSITY (JP) | 2011-08-25 | — | — | US | disclosed |
| US-20110204295-A1 | Novel Heterocyclic Compound And Use Thereof | HIROSHIMA UNIVERSITY (JP) | 2011-08-25 | — | — | US | disclosed |
| US-20110204295-A1 | Novel Heterocyclic Compound And Use Thereof | HIROSHIMA UNIVERSITY (JP) | 2011-08-25 | — | — | US | disclosed |
| WO-2010058833-A1 | NOVEL HETEROCYCLIC COMPOUND AND USE THEREOF | 国立大学法人広島大学 (JP) | 2010-05-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10113065-B1 | Two-photon absorbing compounds and methods of making same | TBXA2R, TBXAS1, TPD52L2 | GSK3B 4858/4885 |
| US-20110204295-A1 | Novel Heterocyclic Compound And Use Thereof | SCLY, C9, C1S | GSK3B 4582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.